H.B. Fuller Company

H.B. Fuller Company (FUL) Market Cap

H.B. Fuller Company has a market capitalization of .

No quote data available.

CEO: Celeste Beeks Mastin

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1968-04-25

Website: https://www.hbfuller.com

H.B. Fuller Company (FUL) - Company Information

Market Cap: -|Sector: Basic Materials

Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives such as, thermoplastic, thermoset, reactive, and water-based and solvent-based products for applications in various markets, including food and beverage containers, flexible packaging, consumer goods, package integrity and re-enforcement, and non-durable goods; corrugation, folding carton, tape and label, paper converting, envelopes, books, multi-wall bags, sacks, and tissue and towel; disposable diapers, feminine care, and medical garments; and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives such as reactive, light cure, two-part liquids, silicone, polyurethane, film, and fast cure products to the appliances and filters, windows, doors and wood flooring, and textile, transportation, electronics, medical, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly through distributors and retailers. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

Analyst Sentiment

74%
Strong Buy

From 7 Active Polls

1Y Forecast: $68.25

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$58

Median

$66

High Bound

$84

Average

$68

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$68.25
▲ +13.98% Upside
Low Target
$58.00
-3% Risk
Median Target
$65.50
9% Mid
High Target
$84.00
40% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HB FULLER (FUL) — Investment Overview

🧩 Business Model Overview

HB Fuller is a specialty manufacturer of adhesives, sealants, and related bonding solutions sold into industrial manufacturing and construction-linked applications. The business translates formulation and application expertise into customer outcomes—improved bonding performance, faster line speeds, better durability, and compliance with evolving environmental and safety requirements.

Value creation typically follows a repeatable pattern: (1) develop application-specific adhesive/coating chemistry and dispensing processes; (2) qualify products with customers’ production lines (requiring technical documentation and trial support); (3) supply ongoing needs through a network of manufacturing sites and distribution channels; and (4) reinforce retention through continuing technical service, troubleshooting, and iterative improvements as customer processes evolve.

💰 Revenue Streams & Monetisation Model

Revenue is generated primarily from the sale of adhesives and related specialty bonding products, with monetisation driven by the product mix between commodity-like adhesive formats and higher-value specialty formulations. While sales are not “subscription” in the software sense, adhesive programs often function with embedded continuity because customers qualify suppliers and maintain line-level consistency across production volumes.

  • Specialty adhesives and systems: Higher margin profile supported by technical differentiation, formulation complexity, and application engineering.
  • General industrial adhesives: More exposed to end-market cyclicality and competitive pricing, but still supported by service and product reliability.
  • Customer technical support and formulation services: Typically bundled into commercial arrangements; the practical monetisation is realized through retained supply and expanded SKUs rather than standalone “consulting” fees.

Margin drivers are largely (1) mix shift toward specialty offerings, (2) ability to manage raw material and freight variability through pricing and sourcing, and (3) operating leverage from utilization in manufacturing footprints.

🧠 Competitive Advantages & Market Positioning

HB Fuller’s moat is best described as high switching costs—earned through qualification processes, line integration, and performance verification requirements that create friction for customers to change suppliers once manufacturing parameters are standardized.

  • Switching costs from qualification and line compatibility: Changing adhesives is not a plug-and-play event; customers require testing for bond strength, cure behavior, substrate compatibility, temperature/humidity performance, and long-term durability.
  • Application engineering as an intangible asset: HB Fuller’s technical support and know-how create repeatable value in optimizing dispensing methods, curing, and defect reduction.
  • Portfolio breadth and solution capability: A wider mix of chemistries supports cross-selling as customers move across product lines and packaging/construction formats.

COMPETITIVE BENCHMARKING

  • Henkel: A large global adhesives and surface technologies player with significant breadth across industrial segments. Henkel competes strongly on scale and system solutions; HB Fuller typically competes by emphasizing customer-specific application performance and maintaining focused technical programs.
  • 3M (industrial adhesives): A broad industrial conglomerate with deep materials science. 3M competes on innovation-driven products and diversified end-market exposure; HB Fuller competes by translating chemistry into practical line outcomes with a strong application-services model.
  • Sika (construction chemicals): A construction-focused chemicals supplier with advantages tied to project and specification-driven procurement. Sika’s construction-centric positioning differs from HB Fuller’s broader industrial adhesives emphasis, where manufacturing qualification and line economics often dominate buying decisions.

Across these rivals, the central distinction for HB Fuller is not only product availability but the execution layer—qualification support, process integration, and sustained technical collaboration that raise customer transition costs.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by secular themes that favor specialty adhesive suppliers with strong application capabilities.

  • Lightweighting and manufacturing efficiency: Adhesive bonding supports weight reduction versus mechanical fastening in many applications and helps enable cleaner assembly design.
  • Packaging evolution and performance requirements: Demand for higher barrier performance, better sealing, and improved throughput supports continued adhesive usage and specialty mix expansion.
  • Regulatory and sustainability-driven formulation shifts: Movement toward lower-emission and water-based/solvent-reduced chemistries rewards suppliers with formulation expertise and regulatory competence.
  • Increased automation and quality standards: Faster lines and stricter defect tolerances increase the value of supplier technical support and stable process performance.
  • Geographic expansion of manufacturing bases: Customers expanding production to new regions often require local sourcing, technical coverage, and validated product performance—areas where established supply networks can gain share.

The total addressable market expands not only through volume growth in end markets, but also through mix—customers often shift from simpler adhesive types toward specialty formulations that reduce defects, improve durability, and meet regulatory requirements.

⚠ Risk Factors to Monitor

  • End-market cyclicality: Industrial production and construction-related activities drive volume variability; resilience depends on specialty mix and pricing actions.
  • Raw material and logistics volatility: Adhesive manufacturing can be exposed to changes in key input costs and freight, requiring disciplined supply-chain management and pricing discipline.
  • Competitive intensity and qualification losses: Customer renewals and new program awards can shift with competitive bids, especially where customers value short-term cost over long-term performance.
  • Environmental and regulatory compliance costs: Reformulation to meet emission and safety standards can increase costs and create execution risk during transition.
  • Capital intensity and footprint optimization: Capacity decisions and manufacturing expansions must align with demand; underutilization can pressure margins.

📊 Valuation & Market View

The market typically values HB Fuller and peer specialty chemical businesses using EV/EBITDA or EV/EBIT metrics, with DCF frameworks that emphasize cash generation, reinvestment needs, and margin durability. Equity investors usually focus on:

  • Margin structure and mix: Specialty mix and the ability to sustain gross margin through pricing power and formulation differentiation.
  • Stability of demand and end-market diversification: Reducing the impact of cyclical swings.
  • Working capital discipline: Adhesives supply chains can be influenced by inventory and pass-through dynamics.
  • Return on invested capital: Efficiency in manufacturing utilization and disciplined capital allocation.

Multiple expansion tends to follow credibility in (1) durable specialty penetration, (2) controlled input cost pass-through, and (3) consistent execution of technical value propositions that protect retention and program wins.

🔍 Investment Takeaway

HB Fuller offers an evergreen specialty chemicals profile anchored by high switching costs and an application-engineering-led value proposition. The long-term thesis centers on maintaining specialty mix, deepening customer technical relationships that reduce churn, and capturing secular demand from lightweighting, packaging performance, and sustainability-driven formulation upgrades. The key debate for investors is whether the company can sustain margin quality and program retention through cyclical periods and competitive bidding while managing input and compliance risks.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-02-28

"FUL’s latest quarter (2026-02-28) reported Revenue of $770.8M and Net Income of $21.0M (EPS $0.38). QoQ, Revenue declined 13.9% (from $894.8M on 2025-11-29) and Net Income fell 29.2% (from $29.7M). YoY growth for Revenue and Net Income could not be calculated because the dataset does not include the same quarter last year. Over the last four quarters, profitability has weakened: net margin dropped from ~4.7% (2025-05-31) to ~7.5% (2025-08-30), then down to ~3.3% (2025-11-29) and ~2.7% (2026-02-28). Cash flow quality also deteriorated—free cash flow swung from +$59.1M (2025-11-29) to -$61.7M (2026-02-28), driven by a shift to negative operating cash flow (-$4.0M). Dividends remain steady at $0.235 per quarter (yield ~0.36%) with a payout ratio of ~0.61 in the latest period. Total shareholder returns appear modest: the stock is up 13.8% over 1 year (not >20%), and no buyback data is provided. With a consensus price target of $73.33 vs. $61.39, analyst expectations imply potential upside, partially offset by current earnings/FCF softness."

Revenue Growth

Caution

QoQ Revenue declined 13.9% (to $770.8M). YoY growth was not computable from the provided history (missing same-quarter-last-year data). Revenue has been volatile across the last four quarters (~$892–$898M in mid/late 2025, then down sharply in the latest quarter).

Profitability

Caution

Net margin contracted materially over the period: ~7.5% (2025-08-30) to ~2.7% (2026-02-28). Net Income fell 29.2% QoQ and EPS declined from $0.55 to $0.38. Over the last four quarters, profitability has deteriorated rather than expanded.

Cash Flow Quality

Neutral

Free cash flow weakened from +$59.1M (2025-11-29) to -$61.7M (2026-02-28). Operating cash flow turned negative (-$4.0M) in the latest quarter, signaling reduced earnings-to-cash conversion near-term.

Leverage & Balance Sheet

Neutral

Total assets edged up to ~$5.22B (from ~$5.13B). Equity strengthened to ~$2.07B from ~$1.88B over the last four quarters, but net debt remains high (~$1.97B), limiting resilience.

Shareholder Returns

Neutral

Stock price is up 13.79% over 1 year (moderate momentum; not >20%). Dividend yield is low (~0.36%) with dividends stable ($0.235 quarterly). Buybacks were not provided, so total return is likely understated by data limitations.

Analyst Sentiment & Valuation

Neutral

Valuation is relatively rich on the latest quarter (P/E ~42.7). However, the consensus price target (~$73.33) is above the current price ($61.39), suggesting analysts see upside despite near-term earnings/FCF softness.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

FUL’s Q1 2026 showed strong cost/mix execution despite volume contraction: adjusted EBITDA of $119M (+4% YoY) and EBITDA margin +90 bps to 15.4%, helped by restructuring (Quantum Leap) and pricing/raw-material actions versus a -6.6% organic revenue decline (pricing +0.6%, volume -7.2%). Management’s core 2026 update hinges on supply-chain shock from the Middle East (40+ force majeure letters), prompting a minimum 10% global price increase effective April 1 and ongoing supplements, with FY guidance raised on earnings power but assuming volume further deteriorates (now down ~5%). Analysts probed whether pricing assumptions remain valid, how much Lunar New Year timing distorted Q1/Q2, and what drives the HHC volume/inventory trend. The central “so what” is a constrained market that can enable share gains, but demand destruction plus customer input/substrate limitations keep volume downside material, increasing reliance on pricing and working-capital management to protect cash flow and margins.

AI IconGrowth Catalysts

  • Minimum 10% global price increase effective April 1, with higher pricing for certain technologies/regions to offset supply shock inflation and protect service levels
  • Market share opportunity from competitors facing raw material uncertainty; management believes they can gain allocation and secure qualified substitutes ahead of broader market
  • Selective share-gain execution by channeling scarce materials to customers that innovate with Fuller (ties to higher-margin spaces in EA and BAS, and HHC opportunities where China-sourced raw materials are directly impacted)
  • Project Quantum Leap redesigned plant and supply chain network remains on track to strengthen long-term competitiveness and improve profitability

Business Development

  • 3 large global existing customers (mentioned by Lucas Beaumont) asked Fuller to supply an additional application after their prior supplier couldn’t supply
  • Relationships and contracting with long-term specialty chemical suppliers (including China supply base); management referenced committing longer-term to suppliers able to supplement needs during force majeure conditions

AI IconFinancial Highlights

  • Organic revenue: -6.6% YoY (pricing +0.6%, volume -7.2%); currency +3.6%; acquisitions +0.7%
  • Adjusted EBITDA: $119,000,000, +4% YoY; EBITDA margin expanded +90 bps to 15.4% (restructuring savings from Quantum Leap + price/raw material actions outweighed lower volume)
  • Adjusted gross margin: 31.3%, +170 bps YoY (positive pricing/raw material actions + restructuring savings more than offset volume)
  • EA: organic revenue +~3% excluding solar/business exit; EBITDA margin +120 bps YoY to 19.9% (net pricing/raw material actions + restructuring)
  • HHC: organic revenue -10% YoY (customers tighter inventory; premium down-trading and smaller package sizes); EBITDA margin 13.9%, +120 bps YoY
  • BAS: organic sales -5.1% YoY; EBITDA -1% YoY; EBITDA margin flat (price/raw actions + restructuring savings offset volume declines)
  • Net debt/adjusted EBITDA: 3.1x (down from 3.5x at end of Q1 prior year)

AI IconCapital Funding

  • Paused near-term M&A closings; evaluating strategic acquisitions but pausing to deploy more cash into share repurchases while targeting net debt/EBITDA of 2.5x to 3.0x
  • Operating cash flow improved by $49,000,000 YoY in Q1; operating cash flow expected to be weighted to 2H 2026

AI IconStrategy & Ops

  • Deployed global sourcing and supply assurance infrastructure: securing raw materials ahead of broader market, reallocating volumes across regions, pursuing qualified substitutes
  • Swift pricing actions tied to raw material and energy/freight inflation; additional supplements negotiated on top of the 10% minimum
  • Execution/visibility into Project Quantum Leap redesign of plant and supply chain network remains on track
  • Inventory management approach may require living with higher inventory to improve supply assurance (per CFO discussion in Q&A)

AI IconMarket Outlook

  • FY 2026 guidance update: net revenue up mid-single digits; organic revenue up low single digits; FX translation expected to positively impact revenue by 1% to 2%
  • FY 2026 adjusted EBITDA: $645,000,000 to $675,000,000; FY 2026 adjusted EPS: $4.55 to $4.90
  • Q2 2026: net revenue up low single digits; adjusted EBITDA $175,000,000 to $185,000,000
  • Within FY 2026 volume framework (CFO/Q&A): pricing/raws drive roughly two-thirds of guidance change; volume assumption revised from flat to down 1% to down 5%

AI IconRisks & Headwinds

  • Middle East conflict supply-chain disruption: chemical capacity down significantly; tanker routes disrupted/repositioned; management cited receiving over 40 force majeure letters from suppliers
  • Broad inflationary pressure and raw material shortages expected to persist as inventories rebalance and logistics normalize (aftershocks through the year)
  • HHC demand pressure: customers tighter inventory management; consumers switching away from premium products; smaller package sizes reduce adhesive usage
  • Volume risk from demand erosion in inflationary environment and uncertainty around customers unable to source other substrates/inputs needed for end products
  • Energy/freight inflation and specialty chemical pricing reset dynamics; VAM spot market in Europe up ~300% recently
  • FX and working capital timing risk: CFO flagged managing inventory may be trickier; potential working capital drag is being monitored

Q&A: Analyst Interest

  • Topic: Price-cost assumption vs guidance cadence (10% price hike); Management's detailed response: Celeste and John said they are baking in additional price and raw material benefits but also negative volume. Two-thirds of the guidance change is pricing/EO raw actions and volume. Organic growth guided to low single digits with pricing averaging ~10%+ for the rest of 2026; volume assumption shifted to down ~5% from flat to down 1%.
  • Topic: HHC volume drivers and inventory tightening trend after Q1; Management's detailed response: Management attributed ongoing HHC pressure to consumer affordability stress. They described inventory management occurring at big customers and distributors, with smaller customers affected by tariffs and inflation. Consumer down-trading to less premium products reduces adhesive usage and shifts demand toward smaller package sizes, lowering glue volume.
  • Topic: Lunar New Year timing, Asia activity, and link to Middle East conflict; Management's detailed response: They quantified Chinese New Year impact of about $15M–$20M revenue in Q1, which rolls into Q2 guidance (Q2 impact roughly ~$20M). Management said China bounced back to double-digit growth excluding Chinese New Year; in January they observed motivated demand and HHC outperformance in Asia driven by hygiene export growth and focus away from lower-cost baby diapers toward higher-end femcare/adult incontinence.

Sentiment: MIXED

Note: This summary was synthesized by AI from the FUL Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — H.B. Fuller Company (FUL) Financial Profile